Home
NSPR
NSPR News

Latest InspireMD Inc. (NSPR) News on July 14, 2025

MT Newswires

19 days ago

InspireMD Gets US FDA Approval for CGuard Prime System to Prevent Strokes; Shares Jump After Hours

InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke

GlobeNewswire

19 days ago

InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

GlobeNewswire

a month ago

InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

GlobeNewswire

a month ago

InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer

GuruFocus.com

2 months ago

InspireMD Inc (NSPR) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Operational Challenges

InspireMD Reports First Quarter 2025 Financial Results

GlobeNewswire

2 months ago

InspireMD Reports First Quarter 2025 Financial Results

InspireMD Inc (NSPR) Q1 2025 Earnings Report Preview: What To Look For

GuruFocus.com

2 months ago

InspireMD Inc (NSPR) Q1 2025 Earnings Report Preview: What To Look For

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

GlobeNewswire

2 months ago

InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference

InspireMD to Announce First Quarter 2025 Financial Results

GlobeNewswire

3 months ago

InspireMD to Announce First Quarter 2025 Financial Results

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

3 months ago

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

GlobeNewswire

4 months ago

InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference

InspireMD Full Year 2024 Earnings: US$0.76 loss per share (vs US$0.82 loss in FY 2023)

Simply Wall St.

4 months ago

InspireMD Full Year 2024 Earnings: US$0.76 loss per share (vs US$0.82 loss in FY 2023)

GuruFocus.com

4 months ago

InspireMD Inc (NSPR) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Rising Expenses and ...

InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

4 months ago

InspireMD Reports Fourth Quarter and Full Year 2024 Financial Results

InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire

5 months ago

InspireMD to Announce Fourth Quarter and Full Year 2024 Financial Results

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years

Simply Wall St.

5 months ago

Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 78% over the last five years

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures

GlobeNewswire

5 months ago

InspireMD and NAMSA to Partner on CGUARDIANS II Pivotal Clinical Trial of the CGuard Prime™ 80 cm Carotid Stent System for Use in TCAR procedures

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

5 months ago

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

6 months ago

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation

Simply Wall St.

6 months ago

Here's Why We're Watching InspireMD's (NASDAQ:NSPR) Cash Burn Situation

InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025

GlobeNewswire

7 months ago

InspireMD Announces Expected Retirement of its CFO Craig Shore and CFO Transition in 2025

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

GlobeNewswire

7 months ago

InspireMD Announces First Patient Enrolled in the CGUARDIANS II Pivotal Study of the CGuard Prime Carotid Stent System in Transcarotid Artery Revascularization Procedures (TCAR)

InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors

GlobeNewswire

8 months ago

InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors

InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023)

Simply Wall St.

8 months ago

InspireMD Third Quarter 2024 Earnings: US$0.16 loss per share (vs US$0.15 loss in 3Q 2023)

GuruFocus.com

8 months ago

InspireMD Inc (NSPR) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Rising Costs and ...

InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

8 months ago

InspireMD Reports Third Quarter 2024 Financial Results and Provides Business Update

What To Expect From InspireMD Inc (NSPR) Q3 2024 Earnings

GuruFocus.com

8 months ago

What To Expect From InspireMD Inc (NSPR) Q3 2024 Earnings

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

8 months ago

InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th

GlobeNewswire

8 months ago

InspireMD to Report Third Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, November 12th

One InspireMD Insider Raised Stake By 13% In Previous Year

Simply Wall St.

9 months ago

One InspireMD Insider Raised Stake By 13% In Previous Year

InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System

GlobeNewswire

9 months ago

InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System

InspireMD Advances with FDA Study Approval and Global Goals

TipRanks

9 months ago

InspireMD Advances with FDA Study Approval and Global Goals

InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System

GlobeNewswire

9 months ago

InspireMD Announces Approval of Investigational Device Exemption (IDE) Application for CGUARDIANS II Pivotal Study of the CGuard Prime 80cm Carotid Stent System

InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System

GlobeNewswire

10 months ago

InspireMD Announces Submission of Premarket Approval Application to FDA Seeking U.S. Regulatory Approval of the CGuard™ Prime Carotid Stent System

Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 88% over the last five years

Simply Wall St.

10 months ago

Investors in InspireMD (NASDAQ:NSPR) have unfortunately lost 88% over the last five years

Companies Like InspireMD (NASDAQ:NSPR) Are In A Position To Invest In Growth

Simply Wall St.

a year ago

Companies Like InspireMD (NASDAQ:NSPR) Are In A Position To Invest In Growth

InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update

InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment

GlobeNewswire

a year ago

InspireMD Congratulates CREST-2 Investigators on Completion of Trial Enrollment

InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th

GlobeNewswire

a year ago

InspireMD to Report Second Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, August 6th

InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million

GlobeNewswire

a year ago

InspireMD Announces Full Exercise of Series H Warrant Tranche for Gross Proceeds of $17.9 Million

InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024

GlobeNewswire

a year ago

InspireMD Announces Presentation of Positive One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial of CGuard at LINC 2024

InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire

a year ago

InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update

InspireMD Insider Ups Holding By 13% During Year

Simply Wall St.

a year ago

InspireMD Insider Ups Holding By 13% During Year

InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th

GlobeNewswire

a year ago

InspireMD to Report First Quarter 2024 Financial Results and Provide Corporate Business Update on Tuesday, May 14th

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

GlobeNewswire

a year ago

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

InspireMD's (NASDAQ:NSPR) investors will be pleased with their solid 110% return over the last year

Simply Wall St.

a year ago

InspireMD's (NASDAQ:NSPR) investors will be pleased with their solid 110% return over the last year

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024

GlobeNewswire

a year ago

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024

InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript

Insider Monkey

a year ago

InspireMD, Inc. (NASDAQ:NSPR) Q4 2023 Earnings Call Transcript

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

GlobeNewswire

a year ago

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th

GlobeNewswire

a year ago

InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th

InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System

GlobeNewswire

a year ago

InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard™ Neuroprotection System

InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework

GlobeNewswire

a year ago

InspireMD Receives CE Mark Recertification Under EU’s New Medical Device Regulation (MDR) Regulatory Framework

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

GlobeNewswire

a year ago

Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

Citizens Community Bancorp, Inc. (NASDAQ:CZWI) most popular amongst retail investors who own 38% of the shares, institutions hold 38%

Simply Wall St.

a year ago

Citizens Community Bancorp, Inc. (NASDAQ:CZWI) most popular amongst retail investors who own 38% of the shares, institutions hold 38%

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely

Simply Wall St.

a year ago

We're Hopeful That InspireMD (NASDAQ:NSPR) Will Use Its Cash Wisely

Nutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and Warrants

PR Newswire

a year ago

Nutex Health Announces Pricing of $10.0 Million Registered Direct Offering of Common Stock and Warrants

Nutex Health Inc.'s (NASDAQ:NUTX) top owners are retail investors with 47% stake, while 43% is held by insiders

Simply Wall St.

a year ago

Nutex Health Inc.'s (NASDAQ:NUTX) top owners are retail investors with 47% stake, while 43% is held by insiders

CPSI and PointClickCare Announce Exclusive Referral Partnership for TruBridge RCM Services to Skilled Nursing Facilities

Business Wire

a year ago

CPSI and PointClickCare Announce Exclusive Referral Partnership for TruBridge RCM Services to Skilled Nursing Facilities

CPSI Announces Divestment of American HealthTech to PointClickCare

Business Wire

a year ago

CPSI Announces Divestment of American HealthTech to PointClickCare

Surf Air Mobility Enters Agreement to Supply Electric Powertrains to Kenya’s Largest Cessna Caravan Charter Operator Z.Boskovic Air Charters

Business Wire

a year ago

Surf Air Mobility Enters Agreement to Supply Electric Powertrains to Kenya’s Largest Cessna Caravan Charter Operator Z.Boskovic Air Charters

Shareholders in Pure Cycle (NASDAQ:PCYO) are in the red if they invested three years ago

Simply Wall St.

a year ago

Shareholders in Pure Cycle (NASDAQ:PCYO) are in the red if they invested three years ago

New to The Street Announces its Televised Five Corporate Interviews, Episodes 547 and 548, Show Airs as Sponsored Programming on Bloomberg TV and the FOX Business Network; Broadcastings Begin on Saturday, January 13, 2024, at 6:30 PM ET

GlobeNewswire

2 years ago

New to The Street Announces its Televised Five Corporate Interviews, Episodes 547 and 548, Show Airs as Sponsored Programming on Bloomberg TV and the FOX Business Network; Broadcastings Begin on Saturday, January 13, 2024, at 6:30 PM ET

P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024

Business Wire

2 years ago

P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024

Argo Blockchain PLC Announces December Update/Management Change/Share Allotment

ACCESSWIRE

2 years ago

Argo Blockchain PLC Announces December Update/Management Change/Share Allotment

Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?

Zacks

2 years ago

Strength Seen in Enanta Pharmaceuticals (ENTA): Can Its 13.8% Jump Turn into More Strength?

Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

2 years ago

Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference

Amprius Successfully Completes First Volume Shipment of Safe Cells for the U.S. Army

Business Wire

2 years ago

Amprius Successfully Completes First Volume Shipment of Safe Cells for the U.S. Army

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America

GlobeNewswire

2 years ago

InspireMD Announces Appointment of Medical Technology Executive Pete Ligotti as Executive Vice President and General Manager of North America

3 Quantum Computing Stocks You’ll Regret Not Buying Soon

InvestorPlace

2 years ago

3 Quantum Computing Stocks You’ll Regret Not Buying Soon

Xiao-I Corporation's (NASDAQ:AIXI) largest shareholders are retail investors with 49% ownership, insiders own 29%

Simply Wall St.

2 years ago

Xiao-I Corporation's (NASDAQ:AIXI) largest shareholders are retail investors with 49% ownership, insiders own 29%

Co-Founder of BioAtla Jay Short Buys 2.3% More Shares

Simply Wall St.

2 years ago

Co-Founder of BioAtla Jay Short Buys 2.3% More Shares

Best Value Stocks to Buy for December 22nd

Zacks

2 years ago

Best Value Stocks to Buy for December 22nd

InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System

GlobeNewswire

2 years ago

InspireMD Announces Issuance of Key U.S. Patent Covering Its SwitchGuard™ Neuroprotection System

NN, Inc. Announces $10M New Business Win in Automotive Electrical Wiring

GlobeNewswire

2 years ago

NN, Inc. Announces $10M New Business Win in Automotive Electrical Wiring

Calculating The Intrinsic Value Of FONAR Corporation (NASDAQ:FONR)

Simply Wall St.

2 years ago

Calculating The Intrinsic Value Of FONAR Corporation (NASDAQ:FONR)

Chijet Motor Company Provides Further Commentary on its Financial Results for the First Half of 2023

GlobeNewswire

2 years ago

Chijet Motor Company Provides Further Commentary on its Financial Results for the First Half of 2023

Scilex Holding Company Announces Expanded Access to ELYXYB® By the Execution of First ELYXYB® Insurance Coverage Agreement with One of the Top Three National PBMs (Pharmacy Benefit Manager) for its Medicare Population

GlobeNewswire

2 years ago

Scilex Holding Company Announces Expanded Access to ELYXYB® By the Execution of First ELYXYB® Insurance Coverage Agreement with One of the Top Three National PBMs (Pharmacy Benefit Manager) for its Medicare Population

Thomson Reuters StreetEvents

2 years ago

Q1 2024 Comtech Telecommunications Corp Earnings Call

Shengfeng Development Limited's (NASDAQ:SFWL) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Simply Wall St.

2 years ago

Shengfeng Development Limited's (NASDAQ:SFWL) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

First National Corporation's (NASDAQ:FXNC) largest shareholders are individual investors with 47% ownership, institutions own 22%

Simply Wall St.

2 years ago

First National Corporation's (NASDAQ:FXNC) largest shareholders are individual investors with 47% ownership, institutions own 22%

ARC Announces Quarterly Dividend

ACCESSWIRE

2 years ago

ARC Announces Quarterly Dividend

MainStreet Bancshares, Inc. (NASDAQ:MNSB) is definitely on the radar of institutional investors who own 45% of the company

Simply Wall St.

2 years ago

MainStreet Bancshares, Inc. (NASDAQ:MNSB) is definitely on the radar of institutional investors who own 45% of the company

InspireMD's Gary Roubin Acquires 13% More Stock

Simply Wall St.

2 years ago

InspireMD's Gary Roubin Acquires 13% More Stock

Institutions own 31% of NN, Inc. (NASDAQ:NNBR) shares but retail investors control 35% of the company

Simply Wall St.

2 years ago

Institutions own 31% of NN, Inc. (NASDAQ:NNBR) shares but retail investors control 35% of the company

InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions

GlobeNewswire

2 years ago

InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions

Sunlands Technology Group (NYSE:STG) Q3 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Sunlands Technology Group (NYSE:STG) Q3 2023 Earnings Call Transcript

Sunlands Technology Group Announces Unaudited Third Quarter 2023 Financial Results

GlobeNewswire

2 years ago

Sunlands Technology Group Announces Unaudited Third Quarter 2023 Financial Results

Be Sure To Check Out First National Corporation (NASDAQ:FXNC) Before It Goes Ex-Dividend

Simply Wall St.

2 years ago

Be Sure To Check Out First National Corporation (NASDAQ:FXNC) Before It Goes Ex-Dividend

STILWELL JOSEPH Bolsters Position in Sound Financial Bancorp Inc

GuruFocus.com

2 years ago

STILWELL JOSEPH Bolsters Position in Sound Financial Bancorp Inc

Standard Lithium Anchors U.S. Lithium Leadership in Smackover Formation, Arkansas, as Global Energy Players Enter the Region

GlobeNewswire

2 years ago

Standard Lithium Anchors U.S. Lithium Leadership in Smackover Formation, Arkansas, as Global Energy Players Enter the Region

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

Insider Monkey

2 years ago

Farallon Capital: A Global and Diversified Hedge Fund and its Top Stock Picks

aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023

GlobeNewswire

2 years ago

aTyr Pharma Presents Poster Demonstrating Preclinical Effects of Efzofitimod in Rheumatoid Arthritis and Rheumatoid Arthritis-Associated ILD at the ACR Convergence 2023

ARC Document Solutions (NYSE:ARC) Might Have The Makings Of A Multi-Bagger

Simply Wall St.

2 years ago

ARC Document Solutions (NYSE:ARC) Might Have The Makings Of A Multi-Bagger

Independent Director of Eastern Picks Up 9.7% More Stock

Simply Wall St.

2 years ago

Independent Director of Eastern Picks Up 9.7% More Stock

IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma

GlobeNewswire

2 years ago

IO Biotech Completes Enrollment of 380 Patients in Pivotal Phase 3 Trial in Advanced Melanoma

There's Reason For Concern Over a.k.a. Brands Holding Corp.'s (NYSE:AKA) Massive 36% Price Jump

Simply Wall St.

2 years ago

There's Reason For Concern Over a.k.a. Brands Holding Corp.'s (NYSE:AKA) Massive 36% Price Jump

Standard Lithium Reports Fiscal First Quarter 2024 Results

GlobeNewswire

2 years ago

Standard Lithium Reports Fiscal First Quarter 2024 Results

Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

GlobeNewswire

2 years ago

Kinnate Biopharma Inc. Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

EMX Receives Q3 Royalty Payment from Esan

Newsfile

2 years ago

EMX Receives Q3 Royalty Payment from Esan

Share on Social Networks: